CAM
Cypress Asset Management’s Novo Nordisk NVO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.19M | Sell |
17,253
-1,142
| -6% | -$78.8K | 0.29% | 61 |
|
|
2025
Q1 | $1.28M | Buy |
18,395
+323
| +2% | +$22.4K | 0.34% | 58 |
|
|
2024
Q4 | $1.62M | Sell |
18,072
-927
| -5% | -$83.1K | 0.4% | 56 |
|
|
2024
Q3 | $2.26M | Buy |
18,999
+933
| +5% | +$111K | 0.56% | 48 |
|
|
2024
Q2 | $2.68M | Buy |
18,066
+150
| +0.8% | +$22.3K | 0.69% | 42 |
|
|
2024
Q1 | $2.39M | Buy |
17,916
+221
| +1% | +$29.5K | 0.65% | 44 |
|
|
2023
Q4 | $1.83M | Buy |
17,695
+935
| +6% | +$96.7K | 0.55% | 50 |
|
|
2023
Q3 | $1.52M | Buy |
16,760
+9,415
| +128% | +$856K | 0.51% | 53 |
|
|
2023
Q2 | $1.22M | Buy |
7,345
+4,500
| +158% | +$747K | 0.39% | 65 |
|
|
2023
Q1 | $453K | Buy |
2,845
+25
| +0.9% | +$3.98K | 0.16% | 99 |
|
|
2022
Q4 | $385K | Hold |
2,820
| – | – | 0.14% | 100 |
|
|
2022
Q3 | $281K | Buy |
+2,820
| New | +$281K | 0.11% | 112 |
|
|
2018
Q1 | – | Sell |
-5,952
| Closed | -$319K | – | 188 |
|
|
2017
Q4 | $319K | Sell |
5,952
-975
| -14% | -$52.3K | 0.07% | 152 |
|
|
2017
Q3 | $334K | Buy |
+6,927
| New | +$334K | 0.07% | 151 |
|
|
2016
Q3 | – | Sell |
-3,927
| Closed | -$211K | – | 208 |
|
|
2016
Q2 | $211K | Hold |
3,927
| – | – | 0.04% | 192 |
|
|
2016
Q1 | $213K | Hold |
3,927
| – | – | 0.04% | 185 |
|
|
2015
Q4 | $228K | Sell |
3,927
-100
| -2% | -$5.81K | 0.05% | 178 |
|
|
2015
Q3 | $218K | Hold |
4,027
| – | – | 0.05% | 179 |
|
|
2015
Q2 | $221K | Hold |
4,027
| – | – | 0.04% | 187 |
|
|
2015
Q1 | $215K | Buy |
+4,027
| New | +$215K | 0.04% | 186 |
|